Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

R-salbutamol sulphate

EU orphan designation number: EU/3/07/481   
Active ingredient: R-salbutamol sulphate
Indication: Treatment of cutaneous forms of lupus erythematosus
Sponsor: Astion Pharma A/S
Fruebjergvej 3, DK-2100 København O, Danmark

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
19/09/2007 Centralised Orphan - Designation EMEA/OD/032/07 (2007)4338 of 14/09/2007